Whole body vibration training in Congenital Myopathies

Not Applicable

Active, not recruiting

• Conditions: Congenital Myopathy; Physical Medicine / Rehabilitation - Other physical medicine / rehabilitation; Musculoskeletal - Other muscular and skeletal disorders; Neurological - Neurodegenerative diseases

• Registration Number: ACTRN12616001471471
• Lead Sponsor: iggins Institute at the University of Auckland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-10-21
• Last Update Posted: 21 September 2020

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

Participants will be aged 4- 16 years and have a confirmed diagnosis of Congenital Myopathy via muscle biopsy and/or genetic testing

Participants are able to:
i) stand on the vibration platform for the duration of treatment sessions, and
ii) undergo some of the clinical and functional assessments necessary to evaluate treatment outcomes.

Exclusion Criteria

1. Recent lower limb fracture and not cleared by an orthopaedic surgeon to participate in the study
2. Cognitive impairment which might affect the ability of participants to comply with testing procedures
3) History of another illness or findings on physical examination, which in the opinion of the investigators would prevent the patient from completing the study;
4) Use for greater than or equal to 30 days of medication that might interfere with study results and assessments within 3 months of enrolment (e.g. anabolic agents);

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in function and mobility as assessed by the 6 minute walk test<br>[Baseline (T0), after a control period of 3 months (T1), after 3 months treatment (T2) after a further 3 month control period (T3), after a second 3 month treatment phase (T4), and after a final 3 month control period (T5)]